开发和评估基于乙烯基硫的-18标签方法,用于构建PSMA向的前列腺癌成像剂
Changjiang Wang1,2, Ruiling Long1,2, Mei Hu1,2
1Department of Nuclear Medicine, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou, Sichuan, China.
Molecular imaging and biology
|July 27, 2025
概括
新的18F标记的放射性追踪剂[18F]4a显示出高稳定性和瘤吸收率,用于前列腺癌 (PCa) 诊断. 这种针对PSMA的药物在临床前模型中表现出与68Ga-PSMA-11相比更高的性能.
科学领域:
- 核医学就是核医学.
- 放射化学 放射化学是指辐射化学.
- 在瘤学瘤学.
背景情况:
- 前列腺特异性膜抗原 (PSMA) 是前列腺癌 (PCa) 的关键生物标志物.
- 18F标记的放射性追踪剂在PSMA成像中比68Ga标记的药物具有优势,包括大规模生产和更长的半衰期.
- 乙烯基硫 (VS) 化学提供了在温和条件下有效标记醇组.
研究的目的:
- 开发和评估使用 VS 化学的新型 18F 标记的 PSMA 向辐射追踪剂.
- 评估这些新型药物的体外和体内PCa检测的性能.
主要方法:
- 六个标有18F的放射性追踪剂被合成,针对PSMA.
- 在体外测试中评估了稳定性,结合亲和力,细胞吸收和内部化.
- 在LNCaP和22RV1瘤携带小鼠的体内研究使用PET/CT成像和生物分布分析.
主要成果:
- 标记物[18F]4a在体外表现出高稳定性 (>2小时后95%纯度).
- [18F]4a在22RV1细胞中表现出显著的细胞吸收和内部化.
- 在体内,[18F]4a在LNCaP和22RV1模型中显示出高瘤吸收率,在LNCaP模型中表现优于[68Ga]PSMA-11.
结论:
- 针对PSMA的辐射追踪器[18F]4a是一种非常有前途的PET剂,用于前列腺癌诊断.
- 其有利的稳定性,吸收和准特征支持其潜在的临床应用.
相关概念视频
Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
853
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
853
![Microwave-assisted One-pot Synthesis of N-succinimidyl-4-[18F]fluorobenzoate [18F]SFB](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F2755.jpg&w=3840&q=50)

